NSE · PAUSHAKLTD · Basic Materials
Paushak Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹231 Cr with net profit ₹39 Cr — a 17.05% net margin, versus 21.93% the period before.
Shareholding
As of 2026-06-30
- Promoter67.28%
- Public32.65%
- DII0.07%
21,399 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.85× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Specialty Chemicals · ranked #1 of 18 by market cap · medians across 1 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sudarshan Colorants India Ltd. | ₹835 Cr | 17.31 | 1.47 | 7.81% | 5.7% |
| Paushak Limited(this company) | — | 114.88 | 2.92 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashPaushak Limited, founded in 1968 and based in Vadodara, India, manufactures and sells specialty chemicals and intermediates globally. The company recorded revenue of Rs 218.60 Cr and a profit margin of 17.99%. Its market capitalization stands at Rs 1347 Cr.
Positives
- +The company's debt-to-equity ratio is low at 0.11.
- +Promoter shareholding is substantial at 67.28% as of March 31, 2026, showing strong insider confidence.
- +There are no promoter share pledges reported for the company.
Negatives
- −Net profit decreased to Rs 39.33 Cr in March 2026 from Rs 49.38 Cr in March 2025.
- −Earnings per share (EPS) declined significantly to Rs 15.95 in March 2026 from Rs 176.35 in March 2024.
- −Quarterly net profit has shown a downward trend, from Rs 12.51 Cr in March 2026 to Rs 6.17 Cr in December 2025.
Business
Paushak Limited operates in the Basic Materials sector, specializing in the manufacturing of specialty chemicals and intermediates. Its product portfolio includes chloroformates, isocyanates, chlorides, carbonate/carbamate, and custom synthesis and CDMO services. The company's products cater to various industries, including pharmaceuticals, agrochemicals, and performance and custom synthesis sectors.
Financial Performance
In the financial year ending March 2026, Paushak Limited reported a revenue of Rs 230.71 Cr. This represents a 5.3% revenue growth compared to the previous period. The company's earnings per share (EPS) for March 2026 stood at Rs 15.95, a decrease from Rs 20.03 in March 2025. Net profit was Rs 39.33 Cr in March 2026.
Profitability & Returns
Paushak Limited's profit margin for the latest period was 17.99%. The company's return on equity (ROE) was 8.01%, while its return on capital employed (ROCE) was 9.02%. The earnings per share (EPS) declined to Rs 15.95 in March 2026 from Rs 176.35 in March 2024.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.11, indicating a limited reliance on debt financing. Book value per share is reported at Rs 199.18. There are no reported promoter pledges, suggesting financial stability regarding promoter shareholding.
Ownership & Pledges
As of March 31, 2026, promoters held 67.28% of the company's shares. Public shareholding was 32.47%, while institutional holdings (DII and FII combined) stood at 0.25%. The company has no reported promoter share pledges.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.